Resistance to cycloguanil pamoate (CI-501) by falciparum malaria in West Pakistan.
D000293:Adolescent; D000962:Antimalarials / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008288:Malaria / Q000188:drug therapy; D008297:Male; D010154:Pakistan; D010963:Plasmodium falciparum / Q000187:drug effects*; D002727:Proguanil; D011739:Pyrimethamine / Q000627:therapeutic use; D011796:Quinacrine / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use
D000962:Antimalarials; D011803:Quinine; D011796:Quinacrine; D002727:Proguanil; D011739:Pyrimethamine